These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15815881)

  • 21. A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor induced disseminated intravascular coagulation in rats.
    Tanabe K; Terada Y; Shibutani T; Kunitada S; Kondo T
    Thromb Res; 1999 Oct; 96(2):135-43. PubMed ID: 10574591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.
    Gerbutavicius R; Iqbal O; Messmore HL; Wehrmacher WH; Hoppensteadt DA; Gerbutaviciene R; Griniute R; Fareed J
    Clin Appl Thromb Hemost; 2003 Oct; 9(4):317-23. PubMed ID: 14653441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis.
    Rogers KL; Chi L; Rapundalo ST; Kramer JB; Gallagher KP
    Basic Res Cardiol; 1999 Feb; 94(1):15-22. PubMed ID: 10097826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats.
    Akahane K; Okamoto K; Kikuchi M; Todoroki H; Higure A; Ohuchida T; Kitahara K; Takeda S; Itoh H; Ohsato K
    Surgery; 2001 Nov; 130(5):809-18. PubMed ID: 11685190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
    Grabowski EF; Kushak RI; Liu B; Ingelfinger JR
    Thromb Res; 2013 Jun; 131(6):521-8. PubMed ID: 23642803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
    Herbert JM; Bernat A; Dol F; Hérault JP; Crépon B; Lormeau JC
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1030-8. PubMed ID: 8786532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.
    Hara T; Yokoyama A; Ishihara H; Yokoyama Y; Nagahara T; Iwamoto M
    Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
    Abendschein DR; Baum PK; Martin DJ; Vergona R; Post J; Rumennik G; Sullivan ME; Eisenberg PR; Light DR
    J Cardiovasc Pharmacol; 2000 May; 35(5):796-805. PubMed ID: 10813384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
    Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodecarboxylation of DX-9065a, a new factor Xa inhibitor, in aqueous solution.
    Kawai Y; Matsubayashi K
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):131-5. PubMed ID: 9468645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation.
    Tanaka M; Arai H; Liu N; Nogaki F; Nomura K; Kasuno K; Oida E; Kita T; Ono T
    Kidney Int; 2005 Jun; 67(6):2123-33. PubMed ID: 15882255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
    Hackeng TM; Seré KM; Tans G; Rosing J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
    Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
    Grabowski EF; Carter CA; Ingelfinger JR; Tsukurov O; Conroy N; Abbott WM; Orkin RW
    Pediatr Res; 1999 Dec; 46(6):742-7. PubMed ID: 10590033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor.
    Cimmino G; Cirillo P; Ragni M; Conte S; Uccello G; Golino P
    J Thromb Thrombolysis; 2015 Aug; 40(2):186-92. PubMed ID: 25712553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats.
    Kaiser B; Paintz M; Scholz O; Kunitada S; Fareed J
    Thromb Res; 2000 Apr; 98(2):175-85. PubMed ID: 10713319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant.
    Wakita Y; Wada H; Nakase T; Nakasaki T; Shimura M; Hiyoyama K; Mori Y; Gabazza EC; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):10-5. PubMed ID: 10725976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.
    Chen D; Riesbeck K; McVey JH; Kemball-Cook G; Tuddenham EG; Lechler RI; Dorling A
    Xenotransplantation; 2001 Nov; 8(4):258-65. PubMed ID: 11737851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.